NDAORALTABLETPriority Review
Approved
Apr 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
3/8 — Basic
Priority Review
TRECATOR (ethionamide) by Pfizer. Approved for tuberculosis. First approved in 1965.
Drug data last refreshed 18h ago
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Clinical Trials (2)
Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis
Started Mar 2026
64 enrolled
Tuberculosis Meningitis
Pharmacokinetics of Ethionamide and Ethionamide Sulfoxide in Patients Established on Treatment for Tuberculosis.
Started Jun 2022
30 enrolled
Tuberculosis, Pulmonary
Company
Worked on TRECATOR at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.